Last reviewed · How we verify

NCT05419921

Comparison of the Diagnostic Accuracy of Hysterosalpingo-lidocaine-foam Sonography Versus Hysterosalpingography in Tubal Patency Assessment to the Gold Standard of Laparoscopy and Dye Testing

Terminated Last updated 6 December 2024
What this trial tests

trial testing Hysterosalpingo-lidocaine-foam-sonography combined with power doppler (HyLiFoSy-PD) in Tubal Factor Infertility in 122 participants. Terminated before completion.

Timeline
1 February 2018
Primary endpoint
31 October 2023
31 October 2023

Quick facts

Lead sponsorCairo University
StatusTerminated
Study typeOBSERVATIONAL
Enrollment122
Start date1 February 2018
Primary completion31 October 2023
Estimated completion31 October 2023
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Cairo University

Who can join

Adults 18 to 40, female only, with Tubal Factor Infertility. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is a cross-sectional study that compares the diagnostic accuracy of Hysterosalpingo-lidocaine-foam sonography combined with power doppler (HyLiFoSy-PD) in the assessment of tubal patency, with the diagnostic accuracy of hysterosalpingogram (HSG), and to the gold standard of laparoscopy and dye testing.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Cairo University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05419921.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing